Health Innovations Pharmacy Recalls Phospholine Iodide Eye Drops
Health Innovations Pharmacy is recalling Phospholine Iodide 0.03% Opth Drops due to quality control issues affecting sterility and stability.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk to sterility and quality assurance for a medical product, which fits the 'High' severity criteria for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Health Innovations Pharmacy, Inc. is recalling all lots of Phospholine Iodide 0.03% Opth Drops. The recall was initiated because recent inspection observations identified deficiencies in quality control procedures that present a risk to the sterility and quality assurance of the product. Additionally, the available stability data does not support the product's expiry date.
The recall is limited to the state of North Carolina. The source text does not specify the number of units affected or report any illnesses or injuries associated with the use of these eye drops.
Consumers who have purchased this product should stop using it and contact Health Innovations Pharmacy at (910) 246-5155 for further instructions.
The recalled product
- Product
- Phospholine Iodide 0.03% Opth Drops, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155
- Manufacturer
- Health Innovations Pharmacy, Inc
- Category
- Drug — Ophthalmic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 65 recalled by Health Innovations Pharmacy, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 65 products in this recall →Related recalls
Same manufacturer · Health Innovations Pharmacy, Inc
See all →- ModerateCarvedilol 1.25 mg/mL Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighProgest Cream Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighNortriptyline Suspension Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighHealth Innovations Pharmacy Recalls Naltrexone Capsules Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereCiprodex with Amphoteracin B Ear Drops Recalled for Sterility Concerns
FDA (Drugs) · 2015-05-20
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighPharmacy Innovations Cyclosporine Eye Drops Recalled for Sterility Defect
FDA (Drugs) · 2023-02-01
- HighFlurbiprofen eye drops recalled for insanitary facility conditions
FDA (Drugs) · 2023-02-01
- SevereNatures Pharmacy Recalls 5-Fluorouracil Eye Drops for Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereNatures Pharmacy Recalls Dexamethasone Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- HighPharmacy Innovations Recalls Estradiol Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighFDA Recalls Scopolamine Ophthalmic Solution for Sterility Assurance Issues
FDA (Drugs) · 2023-02-01